查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1621535

局部止血劑市場：按產品、配方、應用和最終用途 - 全球預測 2025-2030

Topical Hemostat Market by Product, Formulation, Application, End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，局部止血劑市場價值為21.2億美元，預計到2024年將達到22.6億美元，複合年成長率為6.80%，預計到2030年將達到33.6億美元。

局部止血劑透過促進身體的自然凝血過程，對於控制外科手術過程中的出血至關重要。局部止血劑用於醫院、診所和門診手術中心等多個領域，是減少術中和術後出血的重要工具。它在減少手術併發症和改善患者治療效果方面的有效性凸顯了其需求。主要應用在心血管手術、重組手術、整形外科和創傷手術等外科手術。該市場受到手術發生率上升、出血性疾病盛行率增加以及止血產品進步等因素的推動。為了滿足各種外科手術的需求，有很大機會開發先進的止血材料，例如更易於使用且更有效的緩釋性和生物分解性製劑。此外，由於醫療保健支出的增加和基礎設施的發展，新興市場的潛力尚未開發。然而，市場成長受到諸如嚴格的監管要求、潛在的產品召回以及與先進止血設備相關的高成本挑戰的阻礙。為了抓住市場機會，公司應專注於產品開發創新，重點是更快的止血反應和最小的副作用。此外，與醫療機構的聯合研發和數位行銷策略可能會提高市場滲透率。市場競爭激烈，並受到技術進步的推動，需要持續投資研發才能保持領先。進入利基市場並探索組合產品，例如將止血劑和抗生素結合以降低感染風險的產品，可以提供明顯的優勢。總體而言，專注於研究具有成本效益、永續和多功能的止血劑有可能顯著促進市場成長並滿足關鍵的臨床需求。

主要市場統計
基準年[2023] 21.2億美元
預測年份 [2024] 22.6億美元
預測年份 [2030] 33.6億美元
複合年成長率（%） 6.80%

市場動態：快速發展的局部止血劑市場的關鍵市場洞察

供需的動態交互作用正在改變局部止血劑市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 由於人口老化和慢性病流行導致手術數量增加
    • 醫療監管機構的有利產品核可
  • 市場限制因素
    • 與局部止血產品相關的高成本
  • 市場機會
    • 持續研發推出新型外用止血劑
    • 整合奈米技術開發更高效的局部止血材料
  • 市場挑戰
    • 與使用局部止血劑相關的操作限制和感染風險

波特的五力：駕馭局部止血劑市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外用止血劑市場的外部影響

外部宏觀環境因素在塑造外用止血劑市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解外用止血劑市場的競爭狀況

對局部止血劑市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣局部止血劑市場供應商的績效評估

FPNV定位矩陣是評估外用止血劑市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，描繪外用止血劑市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，局部止血劑市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開發：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、未開發地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 由於人口老化和慢性病的蔓延，手術數量不斷增加。
      • 醫療監管機構的有利產品核可
    • 抑制因素
      • 與局部止血產品相關的高成本
    • 機會
      • 正在進行研發以推出新型外用止血劑
      • 整合奈米技術開發更有效率的局部止血劑
    • 任務
      • 與使用局部止血劑相關的操作限制和感染風險
  • 市場區隔分析
    • 產品：由於減少感染等額外好處，複合局部止血劑的採用正在迅速增加。
    • 配方：基質和凝膠止血劑的使用正在擴大，因為它們能夠貼合不規則的傷口表面。
    • 應用：局部止血劑在心血管手術的重要用途
    • 最終用途：醫院局部止血劑使用的演變
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 局部止血劑市場：依產品

  • 膠原蛋白局部止血劑
  • 複方局部止血劑
  • 明膠局部止血劑
  • 氧化再生纖維素系局部止血劑
  • 基於凝血酶的局部止血劑

第7章 處方外用止血劑市場

  • 基質和凝膠止血劑
  • 粉末止血劑
  • 片材和止血墊片
  • 海綿止血劑

第8章局部止血劑市場：依應用分類

  • 心血管外科
  • 一般外科
  • 肝臟和脾臟撕裂
  • 整形外科
  • 重組手術

第9章外用止血劑市場：依最終用途分類

  • 醫院
  • 療養院
  • 手術中心

第10章美洲局部止血劑市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區局部止血劑市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲局部止血劑市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Ethicon 推出 ETHIZIA 止血密封貼片，臨床證明可止血
    • Medcura 的 LifeGel 可吸收手術止血材料獲得突破性器械稱號
    • Hemostasis 完成對 Feargon Medical Technologies 的收購
  • 戰略分析和建議

公司名單

  • Aegis Lifesciences Private Limited
  • Axio Biosolutions Pvt Ltd
  • B.Braun Melsungen AG
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Betatech Medical
  • BioCer Entwicklungs-GmbH
  • Bristol-Myers Squibb Company
  • Dilon Technologies Inc
  • GELITA MEDICAL GmbH
  • Hemostasis, LLC
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.
  • Marine Polymer Technologies, Inc.
  • Medline Industries, LP
  • Medtrade Products Ltd
  • Medtronic PLC
  • Meril Life Sciences Pvt. Ltd
  • Pfizer Inc.
  • Southmedic Inc.
  • Stryker Corporation
  • SYMATESE SAS
  • Takeda Pharmaceutical Company Limited
  • Teleflex Incorporated
  • Zeria Pharmaceutical Co., Ltd.
Product Code: MRR-031AB52F47EB

The Topical Hemostat Market was valued at USD 2.12 billion in 2023, expected to reach USD 2.26 billion in 2024, and is projected to grow at a CAGR of 6.80%, to USD 3.36 billion by 2030.

Topical Hemostats are pivotal in managing bleeding during surgical procedures by accelerating the body's natural clotting process. The scope of topical hemostats spans various sectors including hospitals, clinics, and ambulatory surgical centers, where they serve as critical tools for minimizing intraoperative and postoperative bleeding. Their necessity is underscored by their effectiveness in reducing surgical complications and improving patient outcomes. Key applications involve surgical procedures across cardiovascular, reconstructive, orthopedic, and trauma surgeries. The market is propelled by factors such as the rising incidence of surgeries, increasing prevalence of bleeding disorders, and advancements in hemostatic products. There is a significant opportunity in developing advanced hemostat formulations that combine ease of use with enhanced efficacy, such as time-release formulations and biodegradable options, to cater to diverse surgical needs. Furthermore, emerging markets present untapped potential due to increasing healthcare expenditure and infrastructure development. However, market growth is challenged by factors such as stringent regulatory requirements, potential product recalls, and high costs associated with advanced hemostatic devices. To capture market opportunities, businesses should focus on innovation in product development emphasizing faster hemostatic response and minimal adverse reactions. Additionally, exploring collaborative ventures with healthcare institutions for R&D and leveraging digital marketing strategies could enhance market penetration. The nature of this market is highly competitive and driven by technological advancements, necessitating continuous investment in R&D to stay ahead. Breaking into niche markets and exploring combination products, like those pairing hemostats with antibiotics to reduce infection risks, could offer a distinct advantage. Overall, focused research on cost-effective, sustainable, and multi-functional hemostatic agents could significantly boost market growth and address key clinical demands.

KEY MARKET STATISTICS
Base Year [2023] USD 2.12 billion
Estimated Year [2024] USD 2.26 billion
Forecast Year [2030] USD 3.36 billion
CAGR (%) 6.80%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Topical Hemostat Market

The Topical Hemostat Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising numbers of surgeries due to an aging population and prevalence of chronic diseases
    • Favorable product approval by medical regulators
  • Market Restraints
    • High costs associated with topical hemostat products
  • Market Opportunities
    • Ongoing R&D for the introduction of novel topical hemostat
    • Integration of nanotechnology to create more efficient topical hemostats
  • Market Challenges
    • Operational limitations and risk of infection associated with the use of topical hemostats

Porter's Five Forces: A Strategic Tool for Navigating the Topical Hemostat Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Topical Hemostat Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Topical Hemostat Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Topical Hemostat Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Topical Hemostat Market

A detailed market share analysis in the Topical Hemostat Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Topical Hemostat Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Topical Hemostat Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Topical Hemostat Market

A strategic analysis of the Topical Hemostat Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Topical Hemostat Market, highlighting leading vendors and their innovative profiles. These include Aegis Lifesciences Private Limited, Axio Biosolutions Pvt Ltd, B.Braun Melsungen AG, Baxter International, Inc., Becton, Dickinson and Company, Betatech Medical, BioCer Entwicklungs-GmbH, Bristol-Myers Squibb Company, Dilon Technologies Inc, GELITA MEDICAL GmbH, Hemostasis, LLC, Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Marine Polymer Technologies, Inc., Medline Industries, LP, Medtrade Products Ltd, Medtronic PLC, Meril Life Sciences Pvt. Ltd, Pfizer Inc., Southmedic Inc., Stryker Corporation, SYMATESE SAS, Takeda Pharmaceutical Company Limited, Teleflex Incorporated, and Zeria Pharmaceutical Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Topical Hemostat Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Collagen-Based Topical Hemostats, Combination Topical Hemostats, Gelatin-Based Topical Hemostats, Oxidized Regenerated Cellulose-based Topical Hemostats, and Thrombin-Based Topical Hemostats.
  • Based on Formulation, market is studied across Matrix & Gel Hemostats, Powder Hemostats, Sheet & Pad Hemostats, and Sponge Hemostats.
  • Based on Application, market is studied across Cardiovascular Surgery, General Surgery, Liver & Spleen Lacerations, Orthopedic Surgery, and Reconstructive Surgery.
  • Based on End-Use, market is studied across Hospitals, Nursing Homes, and Surgical Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising numbers of surgeries due to an aging population and prevalence of chronic diseases
      • 5.1.1.2. Favorable product approval by medical regulators
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with topical hemostat products
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing R&D for the introduction of novel topical hemostat
      • 5.1.3.2. Integration of nanotechnology to create more efficient topical hemostats
    • 5.1.4. Challenges
      • 5.1.4.1. Operational limitations and risk of infection associated with the use of topical hemostats
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Burgeoning adoption of combination topical hemostats owing to the additional benefits such as infection reduction
    • 5.2.2. Formulation: Proliferating utilization of matrix and gel hemostats owing to their ability to conform to irregular wound surfaces
    • 5.2.3. Application: Significant usage of topical hemostats in cardiovascular surgery
    • 5.2.4. End-Use: Evolving utilization of topical hemostats in hospitals
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Topical Hemostat Market, by Product

  • 6.1. Introduction
  • 6.2. Collagen-Based Topical Hemostats
  • 6.3. Combination Topical Hemostats
  • 6.4. Gelatin-Based Topical Hemostats
  • 6.5. Oxidized Regenerated Cellulose-based Topical Hemostats
  • 6.6. Thrombin-Based Topical Hemostats

7. Topical Hemostat Market, by Formulation

  • 7.1. Introduction
  • 7.2. Matrix & Gel Hemostats
  • 7.3. Powder Hemostats
  • 7.4. Sheet & Pad Hemostats
  • 7.5. Sponge Hemostats

8. Topical Hemostat Market, by Application

  • 8.1. Introduction
  • 8.2. Cardiovascular Surgery
  • 8.3. General Surgery
  • 8.4. Liver & Spleen Lacerations
  • 8.5. Orthopedic Surgery
  • 8.6. Reconstructive Surgery

9. Topical Hemostat Market, by End-Use

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Nursing Homes
  • 9.4. Surgical Centers

10. Americas Topical Hemostat Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Topical Hemostat Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Topical Hemostat Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Ethicon Introduces ETHIZIA Hemostatic Sealing Patch, Clinically Proven to Stop Disruptive Bleeding
    • 13.3.2. Medcura Receives Breakthrough Device Designation for its LifeGel Absorbable Surgical Hemostat
    • 13.3.3. Hemostasis Closes Acquisition of Fiagon Medical Technologies
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aegis Lifesciences Private Limited
  • 2. Axio Biosolutions Pvt Ltd
  • 3. B.Braun Melsungen AG
  • 4. Baxter International, Inc.
  • 5. Becton, Dickinson and Company
  • 6. Betatech Medical
  • 7. BioCer Entwicklungs-GmbH
  • 8. Bristol-Myers Squibb Company
  • 9. Dilon Technologies Inc
  • 10. GELITA MEDICAL GmbH
  • 11. Hemostasis, LLC
  • 12. Integra LifeSciences Corporation
  • 13. Johnson & Johnson Services, Inc.
  • 14. Marine Polymer Technologies, Inc.
  • 15. Medline Industries, LP
  • 16. Medtrade Products Ltd
  • 17. Medtronic PLC
  • 18. Meril Life Sciences Pvt. Ltd
  • 19. Pfizer Inc.
  • 20. Southmedic Inc.
  • 21. Stryker Corporation
  • 22. SYMATESE SAS
  • 23. Takeda Pharmaceutical Company Limited
  • 24. Teleflex Incorporated
  • 25. Zeria Pharmaceutical Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. TOPICAL HEMOSTAT MARKET RESEARCH PROCESS
  • FIGURE 2. TOPICAL HEMOSTAT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. TOPICAL HEMOSTAT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. TOPICAL HEMOSTAT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TOPICAL HEMOSTAT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TOPICAL HEMOSTAT MARKET DYNAMICS
  • TABLE 7. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY COLLAGEN-BASED TOPICAL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY COMBINATION TOPICAL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY GELATIN-BASED TOPICAL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE-BASED TOPICAL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY THROMBIN-BASED TOPICAL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY MATRIX & GEL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY POWDER HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY SHEET & PAD HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY SPONGE HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY LIVER & SPLEEN LACERATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY NURSING HOMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. DENMARK TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. EGYPT TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. FINLAND TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. ISRAEL TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. NIGERIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. NORWAY TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. POLAND TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. QATAR TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. SWEDEN TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. TURKEY TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 196. TOPICAL HEMOSTAT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 197. TOPICAL HEMOSTAT MARKET, FPNV POSITIONING MATRIX, 2023